Article History
Accepted: 20 December 2022
First Online: 10 February 2023
Declarations
:
: SSK is inventor on patents in the CART cell field that are licensed to Novartis (through an agreement between Mayo Clinic, University of Pennsylvania, and Novartis), Humanigen (through Mayo Clinic), Mettaforge (through Mayo Clinic), MustangBio (through Mayo Clinic), and Sendero (through Mayo Clinic). SSK has received funding from Novartis, Kite/Gilead, Juno/BMS, Lentigen, Humanigen, Tolero, Morphosys, Sunesis, and Viracta, and LeahLabs. SSK has participated in scientific advisory board meetings with Kite/Gilead, Novartis, BMS, CapstanBio, Luminary therapeutics, and Humanigen. SSK has participated in DSMB meetings with Humanigen. SSK has participated in consulting activities with Novartis, Torque, CapstanBio, Luminary therapeutics, and Calibr. SSK hold equity in Life Engine, Inc. and Leahlabs. KLC and ELS have no conflicts to report.
: This article does not contain any studies with human or animal subjects performed by any of the authors.